Pharmaceuticals Businesses for Sale and Investment in Europe
Showing 15 - 23 of 23 Pharmaceuticals Businesses for Sale and Investment in Europe. Buy or Invest in a Pharmaceutical, Alternative Medicine, Biopharmaceutical, Diagnostic Substance Manufacturing, Generic Pharmaceutical, Specialty Pharmaceutical, Veterinary Drug, Nutraceutical or a Pharma Marketing Business. Listed by Direct Business Owners & Business Brokers.
Filters
Pharmaceuticals
Europe
Alternative Medicine Company for Sale in Kilkis, Greece
5 acre field suitable for medical cannabis cultivation, along with the license is for sale.
Looking to sell a company owning a 5 acre field in Greece, best suited for medical cannabis cultivation along with the license form Greek government to build the facility.
- Greece, with its wide-ranging climate and fertile land, is able to produce agricultural products of the highest quality.
- The company at present is not operating and hence not reported any revenue.
- The company will be able to produce 2 ton of medical cannabis oil per crop, up to 5 crops per year.
- Buyer can monetize by finding clients for the business who are mostly multinational pharmaceutical companies, that prefer 5-year contracts for the whole production and pay up to 3,000 EUR per kg.
- Smaller companies in the medical and recreation sectors that buy small quantities (eg 0.5 – 1t) and pay up to 8,000 EUR per kg.
- Business does not have any loans and is run by a sole owner.
Run Rate Sales
Nil
EBITDA Margin
Nil
Ecommerce Website Equity Stake For Sale in Paris, France
E-commerce website dealing with natural food supplements seeks financial investment.
Run Rate Sales
USD
56 thousand
EBITDA Margin
20 - 30 %
Specialty Pharmaceuticals Company Equity Stake For Sale in Nieuwegein, Netherlands
Vertically integrated firm that will be able to produce pharma grade API's from own cannabinoids.
Updates on the business:
The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids.
The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University.
Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program.
Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation.
We have received an installation license for such end products and as the project progresses we will add new products to the list:
- Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption;
- Hemp oil in drops for oral consumption > 0.2% THC;
- Hemp oil for sublingual oral consumption (spray) > 0.2% THC;
- Soft cannabis capsules for oral consumption > 0.2% THC;
- Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption.
At the moment we have:
License and permits;
Architectural and engineering plans;
Purchase offers from equipment suppliers;
All described production processes and laboratories;
Long-term land lease for 30+ years with first an option of first to purchase it;
Long-term lease and right of build on the neighboring land for the second stage of construction;
The entire legal structure of the holding;
Verification of processes and architectural solutions under EU GACP & EU GMP standards.
By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years.
Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards.
The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line.
Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.
Run Rate Sales
Nil
EBITDA Margin
Nil
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors
from 900+ Industries and 170+ Countries
Create Business Profile
Specialty Pharmaceuticals Company Equity Stake For Sale in Nieuwegein, Netherlands
Vertically integrated firm that will be able to produce pharma grade API's from own cannabinoids.
Updates on the business:
The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids.
The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University.
Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program.
Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation.
We have received an installation license for such end products and as the project progresses we will add new products to the list:
- Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption;
- Hemp oil in drops for oral consumption > 0.2% THC;
- Hemp oil for sublingual oral consumption (spray) > 0.2% THC;
- Soft cannabis capsules for oral consumption > 0.2% THC;
- Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption.
At the moment we have:
License and permits;
Architectural and engineering plans;
Purchase offers from equipment suppliers;
All described production processes and laboratories;
Long-term land lease for 30+ years with first an option of first to purchase it;
Long-term lease and right of build on the neighboring land for the second stage of construction;
The entire legal structure of the holding;
Verification of processes and architectural solutions under EU GACP & EU GMP standards.
By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years.
Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards.
The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line.
Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.
Run Rate Sales
Nil
EBITDA Margin
Nil
Alternative Medicine Company for Sale in Lisbon, Portugal
For Sale: Portugal based company involved in cultivating medical cannabis.
Business is involved in the agricultural industry.
- We produce medical cannabis.
- Business produces this cannabis on their own land.
- We own a licence for production.
- Business was awarded as the most potent autoflower in the world for 28% THC.
- We are the highest CBD and THC, cultivators.
- Business has a specific variety with up to 20% CBD with CoA.
- Company is ready to start operating but due to a lack of funds for marketing and operation, the owner wants to sell the business.
- Business has ample potential and opportunity to make profit.
- The selling price includes the stocks that we have.
- Business is open to get investors as well.
- We have attached our pitch deck which we want to present to our buyers/investors.
Run Rate Sales
Nil
EBITDA Margin
Nil
Alternative Medicine Company Seeking Loan in Coimbra, Portugal
European medical cannabis producer and distributor with a license for production, sales, and export.
European company that grows and sells medical cannabis in Europe and to other countries.
- We grow medical cannabis in-house in a controlled environment and distribute them to clients.
- Growing 74 varieties of medical cannabis in all ranges of THC and CBD. Good opportunity for CBD products, since Europe considers it as a controlled substance.
- We used to grow strawberries before and our products were considered the best strawberries in the world that used to sell at EUR 17 per kg.
- We stopped growing strawberries and shifted to medical cannabis due to a family member's health reasons.
- Business owner and management members have a strong knowledge of agriculture, medicine, Olímpic Sport level medicine, and pharmaceuticals.
- Have a stronger demand than before due to Covid-19.
- Have 2 running contracts with medical companies and expect 5-6 new contracts in 1-2 months.
- Each contract is valid for 2-3 years and could be renewed.
- We currently grow 200-300 kgs of medical cannabis and planning to increase the production due to more demand.
- Majority of the clients are from Germany and the Netherlands.
- Also working with 20 distributors who are allowed to buy and sell medical cannabis.
- Have the best equipment and machinery required for the job and the facility including a cloning room, drying room, security facility, and water tanks.
Run Rate Sales
USD
2.95 million
EBITDA Margin
22 %
Specialty Pharmaceuticals Company for Sale in Zaragoza, Spain
For Sale: Nutraceutical product patent and license for fibromyalgia and chronic fatigue syndrome treatment.
Run Rate Sales
Nil
EBITDA Margin
Nil
Profitable Veterinary Drugs Company for Sale in İstanbul, Turkey
For Sale: Fully operational feed additives manufacturing company for agricultural and ruminant animals.
Run Rate Sales
USD
314 thousand
EBITDA Margin
25 %
Alternative Medicine Facility Franchise Opportunity
Arth Ayurveda, 3 Franchisees, Est'd in 1999, Bengaluru HQ
- 7000+ Page Views
- 2000+ Investor Views
At Arth Ayurveda, we believe Ayurveda is the ideal way of life for the 21st century. Our mission is to provide flawless vedic treatment by a team of dedicated professionals. We believe in creating a patient oriented fully integrated healthcare delivery system. We are one of a kind Panchakarma treatment center in Bangalore. We imbibe the logic of natural medication in our treatments on a daily basis, giving a comprehensive and authentic Ayurvedic medication to all the patients.
Exp Monthly Sales
USD
5 thousand
Space Required
1200 - 1500 Sq Ft
Veterinary Drug Distributor Opportunity
Growel, 46 Distributors, Est'd in 2002, Bengaluru HQ
- 9000+ Page Views
- 3000+ Investor Views
Growel Agrovet Private Limited is firm specialised in manufacturing premium quality Pet, Poultry, Cattle and Aqua Healthcare Products & Veterinary Medicine to ensure optimum health, growth and productivity of animals and livestock. We offer superior high performance veterinary medicine & animal healthcare products manufactured using the most advanced manufacturing technology with the best quality ingredients. We also pride ourselves in our effective customer-focused service. This is accomplished through the strong science base and the company’s R&D engine along with a customer-centric approach and a dedicated management team who are involved at the grass roots level and strictly follow the ethics of the veterinary profession with careful concern for the welfare of livestock & pet owners. This company is managed by esteemed veterinary scientists and management professionals and the roots of this company stretch back across the last 14 years.
Exp Monthly Sales
USD
1.08 thousand
Space Required
200 - 1000 Sq Ft
Browse Businesses by Location
Browse Businesses by Industry
Frequently
Asked
Questions
Asked
Questions
-
How many pharmaceuticals businesses for sale and investment in Europe are listed on SMERGERS?There are 23 active and verified pharmaceuticals businesses for sale and investment in Europe listed on SMERGERS as of 10 April 2026.
-
What level of due diligence does SMERGERS conduct on the businesses/member?
SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more
-
How active are the business profiles listed on SMERGERS?
We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.
-
How can I be sure about privacy and confidentiality?
We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more
-
How can I contact a business listed on SMERGERS?
You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more
-
Should you buy an existing business or start a business from scratch?
Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more
-
How successful has SMERGERS been in helping its users successfully close a deal?
SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more
